What is Artiva Biotherapeutics, Inc.'s EBITDA?

Artiva Biotherapeutics, Inc. (ARTV) reported EBITDA of -$23.76M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s EBITDA changed year-over-year?

Artiva Biotherapeutics, Inc.'s EBITDA decreased by 10.3% year-over-year, from -$21.54M to -$23.76M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Artiva Biotherapeutics, Inc. ARTV EBITDA

EBITDA at other companies

Kyverna Therapeutics, Inc.KYTX

-$41.02M+12.6%

Allogene TherapeuticsALLO

-$43.22M+30.4%

Immix Biopharma, Inc.IMMX

-$10.71M-131%

Bristol-Myers SquibbBMY

——

Gilead SciencesGILD

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

−$24.4Mebit+

$666.0KDepreciation Depletion & Amortization

=-$23.76M

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s EBITDA?: Artiva Biotherapeutics, Inc. (ARTV) reported EBITDA of -$23.76M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s EBITDA changed year-over-year?: Artiva Biotherapeutics, Inc.'s EBITDA decreased by 10.3% year-over-year, from -$21.54M to -$23.76M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.